Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea

Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea

US Patent 8658683 · Granted Feb 25, 2014

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosing of incretin pathway drugs2025
Apixaban dosing2025
Methods and systems for providing personalised medicine to a patient2023
Antibacterial compounds2017
Antibacterial compounds2016
Antibacterial compounds2015
Compositions and methods for diagnosis and treatment of tumors2013
Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (ox2013
Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (ox2013
Compositions and methods for diagnosis and treatment of tumors2012
Methods for delivering biologically active molecules into cells2005
Substituted phenyl compounds with a substituent having a thienyl ring2000